期刊文献+

医院获得性肺炎危险因素及用药分析 被引量:15

Risk factors for hospital-acquired pneumonia and analysis of medication
原文传递
导出
摘要 目的探讨医院获得性感染的危险因素及用药分析,从而指导临床治疗。方法收集2010年12月-2011年12月住院的43 200例患者临床资料,对医院获得性肺炎的危险因素及用药情况进行分析。结果发生医院获得性感染患者736例,感染率为1.70%;患者年龄≥60岁、住院天数≥21d、入住重症监护病房、存在基础疾病、抗菌药物的应用>2种均为医院获得性肺炎的危险因素;青霉素类、抗感染类中成药、头孢菌素类、大环内酯类、氨基糖苷类的使用率分别为27.26%、25.07%、19.96%、16.04%、11.67%,中成药在治疗医院获得性肺炎中占有重要地位。结论医院获得性肺炎的发生率较低,应根据该病的危险因素给予有针对性治疗,不可盲目联合给药。 OBJECTIVE To explore the risk factors for hospital-acquired pneumonia and analyze the medication so as to guide the clinical treatment.METHODS From Dec 2007 to Dec 2011,the clinical data of 43 200 patients were collected.The risk factors for hospital-acquired pneumonia and the drug application were analyzed.RESULTS The hospital-acquired pneumonia occurred in totally 736 patients with the infection rate of 1.70%.The patients aged more than 60 years,hospital stay more than 21 days,check in intensive care unit,the underlying diseases,and use of more than 2 antibiotics were the risk factors for the hospital-acquired pneumonia.The utilization rates of penicillin,traditional Chinese medicine for anti-infections,cephalosporins,macrolides,and aminoglycoside were 27.26%,25.07%,19.96%,16.04%,and 11.67%.respectively.Traditional Chinese medicine played an important role in the treatment of hospital-acquired pneumonia.CONCLUSION The incidence of hospital-acquired pneumonia is low in our hospital.The clinician should give targeted therapeutics and should not deliver combination therapies blindly.
作者 金珍
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2012年第20期4467-4468,共2页 Chinese Journal of Nosocomiology
关键词 医院获得性肺炎 危险因素 用药分析 Hospital-acquired pneumonia Risk factors Drug use analysis
  • 相关文献

参考文献3

二级参考文献41

共引文献55

同被引文献115

  • 1张婴元,张敬德,周乐,吴培澄,陈友娣,王宇倩,汪复.头孢哌酮-舒巴坦体外抗菌作用研究[J].中华内科杂志,1995,34(10):676-679. 被引量:52
  • 2闵琦芬,朱春萍,徐萍.引入PDCA循环指导临床护理教学管理的实践与效果[J].护理管理杂志,2006,6(5):39-40. 被引量:39
  • 3张凡非,张晓华.医院消毒存在的问题与对策[J].中国消毒学杂志,2007,24(1):92-93. 被引量:9
  • 4汪复.多重耐药铜绿假单胞菌与鲍曼不动杆菌严重感染的防治策略[J].中国感染与化疗杂志,2007,7(3):230-232. 被引量:139
  • 5Clinical and Laboratory Standards Institute.Performance standardsfor antimicrobial susceptibility testing;twenty-first information sup-plement[S].Wayne PA:CLSI,2011. 被引量:1
  • 6American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management for adults with hospital-aquired, ventilator-associated,and healthcare-associated pneumonia[J]. Am J Respir Crit Care Med,2005,171(4) :388 - 416. 被引量:1
  • 7Magiorakos AP,Srinivasan A,Carey RB, et al. Multidrug-re- sistant ( MDR), extensively drug-resistant (XDR) and pan- drug-resistant(PDR) bacteria in healthcare settings. Expert proposal for a standardized international terminology [EB/ OL]. (2010 - 08)[2015 - 04]. ECDC Entwurf 2010. www. es- emid. Org. 被引量:1
  • 8Rubinstein E,Lalani T,Corey GR,et al.Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens[J].Clin Infect Dis,2011,52(1):31-40. 被引量:1
  • 9Mehrgan H,Rahbar M,Arab-Halvaii Z.High prevalence of extended-spectrum beta-lactamaseproducing Klebsiella pneumoniae in a tertiary care hospital in Tehran,Iran[J].J Infect Dev Ctries,2010,4(3):132-138. 被引量:1
  • 10Giamarellos-Bourboulis EJ,Norrby-Teglund A,Mylona V,et al.Risk assessment in sepsis:a new prognostication rule by APACHEⅡscore and serum soluble urokinase plasminogen activator receptor[J].Crit Care,2012,16(4):149. 被引量:1

引证文献15

二级引证文献111

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部